Redsense receives patent approval in Sweden for its smart wound care technology for optical measuring of blood and exudate
Redsense Medical announces that the company will receive a patent approval in Sweden for the innovative smart wound care technology that was presented in November, 2018. The patent covers optical sensor measuring and will be valid until 2038.Redsense has already received substantial interest in the technology from large international wound care companies. The company expects to have a functional prototype ready in Q2, 2019. “This patent validates that we have created a unique solution that could contribute to improved global wound care. We are aiming to create a strong patent protection